Led by world-renowned expert Dr. David Chereney, this presentation delves into emerging strategies beyond Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors in Chronic Kidney Disease (CKD) management.
Apply expert consensus recommendations to identify and classify patients with ADPKD and recognize knowledge gaps and construct a plan to integrate recent evidence into practice.
Listen to this engaging, case-based vodcast series hosted by renowned Canadian nephrologists and their guest peers as they converse about the recently published 2021 KDIGO guidelines
Renowned experts as they discuss and share their experience in autosomal dominant polycystic kidney disease (ADPKD) management
UKidney answers your nephrology questions! Feel free to search our previous submissions or create your own today.
Ask a new question